Lv3
378 积分 2024-04-17 加入
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
1天前
待确认
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
2个月前
已完结
Emerging Advances in Nano-biomaterial Assisted Amyloid Beta Chimeric Antigen Receptor Macrophages (CAR-M) Therapy: Reducing Plaque Burden in Alzheimer's Disease
5个月前
已完结
A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
7个月前
已完结
Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer
8个月前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
8个月前
已完结
CAR T cell combination therapies to treat cancer
8个月前
已完结
Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
11个月前
已完结
皖公网安备34019202002308
